个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共35条记录  
  • Tuning RNA Interference by Enhancing siRNA/PAZ Recognition
    [作者:GAGLIONE MARIA; POTENZA NICOLETTA; DI FABIO GIOVANNI; ROMANUCCI VALERIA; MOSCA NICOLA; RUSSO ANIELLO; NOVELLINO ETTORE; COSCONATI SANDRO; MESSERE ANNA,期刊:ACS Medicinal Chemistry Letters, 页码:75-78 , 文章类型: Article,,卷期:2013年4-1]
  • Chemically modified siRNAs were synthesized to enhance the corresponding silencing activities. The introduced modifications endowed siRNAs with high silencing effect, long RNAi persistence, and better serum resistance. T...
  • Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor
    [作者:CHAN BRYAN K; ESTRADA ANTHONY A; CHEN HUFFEN; ATHERALL JOHN; BAKERGLENN CHARLES; BERESFORD ALAN; BURDICK DANIEL J; CHAMBERS MARK; DOMINGUEZ SARA L; DRUMMOND JASON; GILL ANDREW; KLEINHEINZ TRACY; LE PICHON CLAIRE E; MEDHURST ANDREW D; LIU XINGRONG; MOFFAT JOHN G; NASH KEVIN; SCEARCELEVIE KIMBERLY; SHENG ZEJUAN; SHORE DANIEL G; VAN DE POEL HERVE; ZHANG SHUO; ZHU HAITAO; SWEENEY ZACHARY K,期刊:ACS Medicinal Chemistry Letters, 页码:85-90 , 文章类型: Article,,卷期:2013年4-1]
  • The modulation of LRRK2 kinase activity by a selective small molecule inhibitor has been proposed as a potentially viable treatment for Parkinson's disease. By using aminopyrazoles as aniline bioisosteres, we discovered ...
  • Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design
    [作者:CHENG HENGMIAO; LI CHUNZE; BAILEY SIMON; BAXI SANGITA M; GOULET LANCE; GUO LISA; HOFFMAN JACQUI; JIANG YING; JOHNSON THEODORE OTTO; JOHNSON TED W; KNIGHTON DANIEL R; LI JOHN; LIU KEVIN K C; LIU ZHENGYU; MARX MATTHEW A; WALLS MARLENA; WELLS PETER A; YIN MINJEAN; ZHU JINJIANG; ZIENTEK MICHAEL,期刊:ACS Medicinal Chemistry Letters, 页码:91-97 , 文章类型: Article,,卷期:2013年4-1]
  • PI3K, AKT, and mTOR are key kinases from PI3K signaling pathway being extensively pursued to treat a variety of cancers in oncology. To search for a structurally differentiated back-up candidate to PF-04691502, which is ...
  • Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349
    [作者:PEI ZHONGHUA; BLACKWOOD ELIZABETH; LIU LICHUAN; MALEK SHIVA; BELVIN MARCIA; KOEHLER MICHAEL F T; ORTWINE DANIEL F; CHEN HUIFEN; COHEN FREDERICK; KENNY JANE R; BERGERON PHILIPPE; LAU KEVIN; LY CUONG; ZHAO XIANRUI; ESTRADA ANTHONY A; TOM TRUONG; EPLER JENNIFER A; NONOMIYA JIM; LAN TRINH; SIDERIS STEVE; LESNICK JOHN; BAO LINDA; VIJAPURKAR ULKA; MUKADAM SOPHIE; TAY SUZANNE; DESHMUKH GAURI; CHEN YUNGHSIANG; DING XIAO; FRIEDMAN LORI S; LYSSIKATOS JOSEPH P,期刊:ACS Medicinal Chemistry Letters, 页码:103-107 , 文章类型: Article,,卷期:2013年4-1]
  • Aberrant activation of the PI3K-Akt-mTOR signaling pathway has been observed in human tumors and tumor cell lines, indicating that these protein kinases may be attractive therapeutic targets for treating cancer. Optimiza...
  • Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes
    [作者:WAN ZHAOKUI; CHENAIL EVA; LI HUANQIU; IPEK MANUS; XIANG JASON; SURI VIPIN; HAHM SEUNG; BARD JOEL; SVENSON KRISTINE; XU XIN; TIAN XIANBIN; WANG MENGMENG; LI XIANGPING; JOHNSON CHRISTIAN E; QADRI ARIFUL; PANZA DARRELL; PERREAULT MYLENE; MANSOUR TAREK S; TOBIN JAMES F; SAIAH EDDINE,期刊:ACS Medicinal Chemistry Letters, 页码:118-123 , 文章类型: Article,,卷期:2013年4-1]
  • 11 beta-Hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) catalyzes the conversion of inactive glucocorticoid cortisone to its active form, cortisol. The glucocorticoid receptor (GR) signaling pathway has been linked to...
共35条记录 第一页 1 2 3 下一页 最后一页